Johnson & Johnson guides to 8.2% adjusted EPS growth at its 2026 midpoint, compared with approximately 7% implied by 2026 ...
The Moscow Times on MSN
Putin’s daughter says fear of death will drive advances against aging
President Vladimir Putin’s daughter Maria Vorontsova said advances in medicine could help address aging within the next 10 to ...
The Company remains on track to complete 12-month visits by early Q2 2027. Envoy Medical has submitted two of the four ...
Larger Human-Submitted Dataset Now Ready for Public Technical Update as Testing Continues MESA, AZ / ACCESS Newswire / October 20, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced th ...
EXPRESS Phase 2 design finalized: 52 weeks of dosing of approximately 60 patients randomized 1:1 to exaluren or placebo, with ...
Mr. Trump credited the first lady with conceiving the idea for a women's health division within NIH. The first lady added her ...
Larger Human-Submitted Dataset Now Ready for Public Technical Update as Testing Continues MESA, AZ / ACCESS Newswire / ...
EXPRESS Phase 2 design finalized: 52 weeks of dosing of approximately 60 patients randomized 1:1 to exaluren or placebo, with annualized htTKV growth as the primary ...
Hengrui Pharma will present 64 research findings at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, from October ...
Nobel-winning scientific breakthroughs have repeatedly emerged from organisms once considered too simple or too distant from human biology to be useful. Research on yeast revealed fundamental ...
HYDERABAD - The National Cancer Conference 2026 began at Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro on Monday, bringing ...
Anteris Technologies Global Corp. ('Anteris” or the 'Company”) (NASDAQ: AVR, ASX: AVR) announced today that it has received full regulatory clearance from the German Federal Institute for Drugs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results